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Abstract 17 
Background: Early studies on COVID-19 identified unequal patterns in hospitalization and 18 
mortality in urban environments for racial and ethnic minorities. These studies were primarily 19 
single center observational studies conducted within the first few weeks or months of the 20 
pandemic. We sought to examine trends in COVID-19 morbidity and mortality over time for 21 
minority and rural populations, especially during the U.S. fall surge. 22 
Methods: Statewide cohort of all adult residents in Indiana tested for SARS-CoV-2 infection 23 
between March 1 and December 31, 2020, linked to electronic health records. Primary 24 
measures were per capita rates of infection, hospitalization, and death. Age adjusted rates 25 
were calculated for multiple time periods corresponding to public health mitigation efforts. 26 
Results: Morbidity and mortality increased over time with notable differences among sub-27 
populations. Initially, per capita hospitalizations among racial minorities were 3-4 times higher 28 
than whites, and per capita deaths among urban residents were twice those of rural residents. 29 
By fall 2020, per capita hospitalizations and deaths in rural areas surpassed those of urban 30 
areas, and gaps between black/brown and white populations narrowed. Cumulative morbidity 31 
and mortality were highest among minority groups and in rural communities. 32 
Conclusions:  Burden of COVID-19 morbidity and mortality shifted over time, creating a 33 
twindemic involving disparities in outcomes based on race and geography. Health officials 34 
should explicitly measure disparities and adjust mitigation and vaccination strategies to protect 35 
vulnerable sub-populations with greater disease burden.  36 
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Introduction 37 
The rapid spread of coronavirus disease 2019 (COVID-19), caused by the severe acute 38 
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has challenged health systems. As of 39 
January 31, 2021, more than 102 million individuals were infected, and over 2.2 million 40 
individuals have died from COVID-19 globally.[1] In the United States, there are over 26 million 41 
cases, 131,384 hospitalizations, and 440,000 deaths associated with COVID-19. At the end of 42 
2020, the US Centers for Disease Control and Prevention (CDC) reported a COVID-19-associated 43 
hospitalization rate of 326.7 per 100,000 population.[2] 44 
Data from China, Italy, the US, and other nations suggest that hospitalization and mortality are 45 
associated with age as well as gender, in which older and male populations are at higher risk of 46 
severe outcomes including death.[3-5] Moreover, early evidence in the US identified unequal 47 
patterns in hospitalization and mortality from COVID-19 in dense urban environments with 48 
respect to race and ethnicity.[6, 7] Existing studies, however, are limited with respect to both 49 
scope and temporality. Early evidence largely comes from single, urban center studies or 50 
regional data during the first wave[8, 9] of the COVID-19 pandemic. Subsequent waves, or 51 
surges, have not been examined. For example, it is unclear whether the same populations were 52 
impacted in fall versus the spring 2020. Furthermore, most studies examine patients after 53 
inpatient admission. There are limited studies on individuals with COVID-19 in community 54 
settings. For example, early data suggested that testing rates per capita were unequal in the US 55 
with respect to race and ethnicity,[10] yet it is unclear how these rates have changed over time. 56 
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There further exists little evidence on individuals in rural communities, and few studies that 57 
compare rural patients to those in urban settings. Nearly 1-in-5 Americans live in a rural 58 
county,[11] which are often labeled as medically underserved areas. Using data from CDC 59 
gathered two years before the pandemic, Kaufman et al.[12] estimate rural residents to be at 60 
increased risk of hospitalization and death from COVID-19. In a single site study in rural 61 
Georgia, individuals hospitalized with COVID-19 from March to May 2020 found that, despite a 62 
higher burden of comorbid conditions, both critical care and in-hospital mortality was lower 63 
than in New York City, as well as China and Italy.[13] Given limited data from rural 64 
communities, more study is warranted.  65 
No studies to date examine the resurgence of COVID-19 infections within the US during the fall, 66 
and little is known about shifts in morbidity and mortality over time from COVID-19. This study 67 
examines the epidemiologic trends in COVID-19 infection, hospitalization, and death in Indiana 68 
with a focus on health equity. The study examines a large, statewide cohort, including 69 
individuals tested by local and state health departments. It further examines care delivered at a 70 
wide array of settings, including critical access hospitals and rural county hospitals. Per capita 71 
rates, when stratified by age, race, sex, and geography, can shed light on changes in morbidity 72 
and mortality over time, as well as within and among sub-populations. Understanding patterns 73 
of COVID-19 morbidity and mortality beyond individual health systems and major metropolitan 74 
areas can inform national strategies to mitigate the ongoing spread of COVID-19, including 75 
vaccination strategies that seek to immunize based primarily on age. 76 
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Methods 78 
Setting 79 
The setting for this study is the State of Indiana, which is the 16
th
 largest state in the US with 80 
respect to population density and 38
th
 by area. The state has a growing population of 6,732,219 81 
individuals, of which 5,063,133 (75.2%) are adults. Approximately 21.7% of residents reside in a 82 
rural county. 83 
The State of Indiana reported its first case of COVID-19 on March 6, 2020. Similar to many 84 
locations, Indiana implemented public health interventions, including a stay-at-home order, to 85 
mitigate spread of COVID-19. On May 1, 2020, following declining rates of hospitalization for 86 
COVID-19, the Governor ended the stay-at-home order and initiated a phased re-opening 87 
plan.[14] New cases increased while hospitalizations declined into the summer, flattening until 88 
a second wave began following Labor Day. The second wave consisted of steady increases in 89 
new cases as well as hospitalizations and deaths, all of which climbed through the holidays 90 
before leveling off towards the end of the year. 91 
Data and Sources 92 
We use data from multiple sources integrated into the Regenstrief Institute COVID-19 93 
Dashboard,[15] a data visualization tool developed in response to the pandemic that leverages 94 
clinical and administrative health data from the Indiana Network for Patient Care (INPC).[16] 95 
The INPC is one of the nation’s largest health information networks, which includes 38 distinct 96 
health systems representing more than 100 hospitals, commercial laboratories, and physician 97 
practices across Indiana.[17] The INPC further includes COVID-19 test results from the Indiana 98 
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Department of Health (IDOH), which receives test results from large commercial labs 99 
contracted for pandemic response as well as local health departments which perform strategic 100 
testing in communities identified as high risk, such as nursing homes, prisons, and homeless 101 
shelters. All testing data, regardless of source, are linked to hospitalization data as well as death 102 
records from IDOH. The combined data represent >95% of the 5 million adult residents who 103 
interact with the state’s health system. 104 
We extracted data on all adults (age ≥18 years) tested for COVID-19 in the health system or 105 
community, as well as those diagnosed with COVID-19 during a clinical encounter. For each 106 
individual, we queried the following information from the INPC: COVID-19 test results, age, sex, 107 
race, hospitalizations up to 21 days before or after a positive COVID-19 test, and geography 108 
associated with home address. Hospitalizations before positive diagnosis were included due to 109 
delays in testing, especially at the start of the epidemic. During March and April 2020, most 110 
patients infected with the SARS-CoV-2 virus were admitted with COVID-like symptoms before 111 
testing positive. All positive cases were identified using RT-PCR tests recorded in medical 112 
records or reported to the public health department, including community-based testing efforts 113 
statewide by public health authorities. Individuals testing positive were only counted once, 114 
during the period of their first positive result. All patient addresses were geocoded using an 115 
established method[18] with rurality determined by a classification system developed by 116 
Purdue University for Indiana’s geography based on ZIP Code.[19]  117 
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Data Analysis 119 
We used epidemiological methods to calculate descriptive statistics, including rates per 100,000 120 
population, also known as per capita rates. These rates provide an objective method for 121 
comparing population characteristics when communities or groups vary in size. Denominator 122 
data for calculating per capita rates came from 2018 U.S. Census estimates. All rates were age-123 
adjusted using American Community Survey estimates. 124 
Statistics were calculated overall and for multiple time periods corresponding to the state’s 125 
initial lockdown and subsequent re-opening plan. We examined data from the start of the 126 
Indiana epidemic (March 6, 2020) thru the end of the stay-at-home order (April 30, 2020), 127 
referred to as Phase 1. Following the stay-at-home order, Indiana initiated a staged reopening. 128 
Each subsequent stage reopened additional sectors of the economy or expanded capacity in a 129 
given sector. Full details of each stage can be found on the Governor’s Back on Track 130 
website.[14] The reopening occurred from May 1, 2020 through September 7, 2020 (Labor 131 
Day), when the only remaining restrictions included a statewide mask ordinance and a 132 
restriction on gatherings larger than 250 people. This is referred to as Phase 2. Finally, we 133 
examined data from September 8, 2020 through December 31, 2020, referred to as Phase 3. 134 
Institutional review board approval for the study was obtained from Indiana University. 135 
Results 136 
Through December 31, 2020, a total of 1,833,218 unique, adult Indiana residents were tested 137 
for COVID-19, which accounts for 36.2% of the statewide adult population. Of those tested, 138 
354,539 (19.3%) unique individuals tested positive for COVID-19 infection. Among those 139 
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infected, 31,352 (8.8%) were hospitalized. A total of 8,104 (0.2% of infected individuals) died 140 
either during their hospital course or at home following COVID-19 infection. 141 
Overall COVID-19 Infection and Burden 142 
Characteristics, as well as morbidity and mortality, of individuals tested for COVID-19 in Indiana 143 
are summarized in Table 1. More women than men per capita were tested and positive for 144 
COVID-19, yet men had higher hospitalizations and mortality per capita compared to women. 145 
With respect to age, testing and morbidity were highest in the younger (0-29) and older (80+) 146 
groups. Hospitalization and mortality per capita increased with age, with older (70+) 147 
populations possessing significantly higher hospitalizations and deaths per capita. With respect 148 
to race, morbidity, hospitalization, and mortality rates per capita were higher among racial 149 
minority groups, especially Native Hawaiian/Pacific Islanders, American Indian/Native Alaskans, 150 
and African Americans respectively. Individuals who did not report their race during testing or 151 
hospitalization also possessed high rates of morbidity and mortality. With respect to geography, 152 
urban residents were tested more frequently. However, per capita morbidity, hospitalization, 153 
and mortality were highest among rural populations. 154 
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Table 1. Characteristics and rates for Indiana residents tested for, infected with, hospitalized with, and death following infection 156 
from COVID-19 through December 31, 2020; State of Indiana. 157 
Characteristics Individuals Tested for COVID-19 COVID-19 Cases COVID-19 Hospitalizations COVID-19 Deaths 
  N % rate per 
capita* 
N % rate per 
capita* 
N % rate per 
capita* 
N % rate per 
capita* 




619.2 8104 160.1 
 
          
  Gender 
           Female 1031547 56.3% 39709.7 190632 53.8% 7338.4 15890 50.7% 611.7 4008 49.5% 154.3 
Male 790687 43.1% 32071.2 162363 45.8% 6585.6 15459 49.3% 627.0 4073 50.3% 165.2 
         
 
  Age Category 
        
 
  18-19 73702 4.0% 39707.1 14169 4.0% 7633.6 130 0.4% 70.0 2 0.0% 1.1 
20-29 357306 19.5% 39038.2 70064 19.8% 7655.0 1472 4.7% 160.8 38 0.5% 4.2 
30-39 312253 17.0% 37227.7 58867 16.6% 7018.3 1950 6.2% 232.5 75 0.9% 8.9 
40-49 284677 15.5% 34644.3 59479 16.8% 7238.4 2771 8.8% 337.2 154 1.9% 18.7 








 4.0 International license
It is m
ade available under a 
 is the author/funder, w
ho has granted m
edR













he copyright holder for this preprint 
this version posted M







60-69 258639 14.1% 34580.4 46261 13.0% 6185.2 6756 21.5% 903.3 1244 15.4% 166.3 
70-79 157831 8.6% 38123.8 27605 7.8% 6667.9 7241 23.1% 1749.1 2038 25.1% 492.3 
80+ 93972 5.1% 38238.7 19554 5.5% 7956.8 6301 20.1% 2564.0 4145 51.1% 1686.7 
         
 
  Race 
        
 
  White 1420211 77.5% 32772.9 272622 76.9% 6291.1 24140 77.0% 557.1 6538 80.7% 150.9 
African American 164730 9.0% 37075.1 31596 8.9% 7111.2 4922 15.7% 1107.8 952 11.7% 214.3 
Asian 29043 1.6% 23872.1 5638 1.6% 4634.2 353 1.1% 290.2 54 0.7% 44.4 
American Indian / Native 
Alaskan 
3961 0.2% 35423.0 1193 0.3% 10668.9 69 0.2% 617.1 4 0.0% 35.8 
Native Hawaiian / Pacific 
Islander 
3057 0.2% 142783.7 783 0.2% 36571.7 79 0.3% 3689.9 19 0.2% 887.4 
Other or Unknown 212216 11.6% 194470.6 42707 12.0% 39135.9 1789 5.7% 1639.4 537 6.6% 492.1 
            Geography 
           Rural 379567 20.7% 34585.2 82276 23.2% 7496.8 6962 22.2% 634.4 1890 23.3% 172.2 
Urban 1453651 79.3% 36656.1 272263 76.8% 6865.5 24390 77.8% 615.0 6214 76.7% 156.7 
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Comparison of infection, hospitalization, and death over time 159 
Table 2 summarizes per capita testing, infections, hospitalizations, and deaths during the three 160 
phases of the COVID-19 epidemic in Indiana through the end of 2020. Testing, infection, 161 
hospitalization, and death per capita all increased over time. Furthermore, there are notable 162 
differences among sub-populations. 163 
Testing and morbidity for women was higher in each phase. Hospitalization and death due to 164 
COVID-19 was higher for women only in Phase 2. Men experienced worse outcomes even 165 
though women experienced higher morbidity per capita. 166 
At the beginning of the pandemic, testing rates were highest in adults 70 years and above. 167 
During Phase 2 and Phase 3, per capita testing increased among all groups, but the highest 168 
rates were observed in young adults and older adults (70+). Morbidity, hospitalization, and 169 
death increased with age and increased across phases for all groups. No deaths occurred 170 
among adults aged 18-19 years during the first two phases; there were 0.2 deaths per 100,000 171 
population for this age group in Phase 3. Deaths among those 70-79 years and those 80+ years 172 
doubled over time, and these rates were 2-10 times higher than younger age groups. 173 
  174 
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Table 2. Comparison of per capita rates for COVID-19 infection, hospitalization and death for residents across three phases of the 175 
epidemic; State of Indiana. 176 
Characteristics COVID-19 Cases COVID-19 Related 
Hospitalization 
COVID-19 Related Deaths 



























Total 402.8 1375.2 5224.4 84.6 133.3 402.5 41.5 41.1 77.5 
          
Gender          
Female 419.4 1421.9 5497.2 80.3 134.5 398.2 39.8 41.9 72.6 
Male 377.3 1308.1 4900.3 89.1 132.1 406.8 42.5 40.1 82.6 
          
Age Category          
18-19 83.5 2003.1 5547.0 5.4 23.2 42.0 0.0 0.0 0.2 
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30-39 370.3 1377.3 5270.7 35.2 62.1 135.9 2.3 2.7 3.9 
40-49 426.8 1379.4 5432.3 58.2 89.9 190.1 5.1 5.7 7.9 
50-59 416.2 1144.5 4986.8 88.7 119.0 322.0 13.3 12.0 20.4 
60-69 396.7 1016.1 4772.5 126.1 181.2 598.2 43.7 39.8 82.8 
70-79 480.7 1084.1 5103.4 199.5 330.7 1221.0 116.9 125.4 250.0 
80+ 1026.6 1501.5 5428.7 323.5 502.1 1743.2 446.8 436.6 803.3 
          
Race          
White 287.2 1068.1 4935.9 62.4 109.2 386.5 35.3 36.5 79.1 
African American 926.4 1816.3 4368.5 285.8 287.6 536.1 89.1 63.0 62.1 
Asian 433.2 922.2 3278.8 51.0 87.1 152.1 14.8 10.7 18.9 
American Indian / Native 
Alaskan 
3559.3 2012.2 5097.5 232.5 152.0 241.5 8.9 0.0 26.8 
Native Hawaiian / Pacific 
Islander 
2942.6 10462.4 23166.7 747.3 747.3 2195.2 186.8 280.2 420.4 
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Geography          
Rural 355.9 1232.6 5908.2 51.6 124.5 459.7 24.7 43.7 103.8 
Urban 415.8 1414.6 5035.2 93.7 135.8 386.6 46.1 40.4 70.2 
 177 
Footnote: Phase 1 (March – April, 2020); Phase 2 (May 1, 2020 – September 7, 2020); Phase 3 (September 8, 2020 – December 31, 178 
2020) 179 
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Testing, morbidity, hospitalization, and mortality generally increased for each racial group over 181 
time, with two exceptions. Morbidity, hospitalization, and deaths decreased between Phase 1 182 
and 2 for American Indian/Native Alaskans. Per capita hospitalization and mortality decreased 183 
for African Americans, especially between Phase 2 and Phase 3. Comparing Whites with African 184 
Americans, however, reveals major disparities. Testing and morbidity per capita was higher for 185 
African Americans, except in Phase 3. Hospitalizations were higher for African Americans in all 186 
phases (Figure 1). Mortality was higher for African Americans in the first two phases. 187 
Fig 1. Per capita rates for hospitalizations and deaths due to COVID-19 among adults in Indiana, 188 
stratified by race, during three distinct time periods between March 1 and December 31, 2020. 189 
State of Indiana.  190 
In each phase, testing per capita was highest for urban residents. Morbidity and hospitalizations 191 
were also higher for urban populations during the first two phases. Deaths were higher among 192 
urban populations only in Phase 1. Over time, per capita morbidity (Figure 2) and negative 193 
outcomes, hospitalization and mortality (Figure 3), shifted to rural populations. Morbidity 194 
shifted in Phase 3 following the conclusion of the state’s re-opening plan. Higher per capita 195 
hospitalization and mortality among rural populations began towards the end of Phase 2 then 196 
accelerated in Phase 3. 197 
Fig 2. Weekly COVID-19 incidence, defined as cases per 100,000 population, among adults in 198 
Indiana, stratified by urban versus rural county of residence between March 1 and December 199 
31, 2020. State of Indiana. 200 
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Fig 3. Weekly rates per capita for hospitalizations and deaths due to COVID-19 among adults in 201 
Indiana, stratified by urban versus rural county of residence between March 1 and December 202 
31, 2020. 203 
Discussion 204 
Among a statewide cohort of individuals tested for COVID-19, we examined epidemiological 205 
trends in testing, infection, hospitalization, and death among three time periods corresponding 206 
to mitigation efforts by public health authorities. Infections due to the SARS-CoV-2 virus 207 
increased over time across the entire state, across the three phases, yet its impact was not 208 
even across sub-populations. Following the initial lockdown in the spring, testing, as well as 209 
morbidity, hospitalizations, and mortality, increased over time. During the summer months, the 210 
gap between White and African American morbidity and mortality narrowed, although burden 211 
remained higher among African American populations. As summer turned into fall, burden 212 
among rural communities increased and surpassed urban communities through the end of the 213 
year. These trends reveal a twindemic, not of influenza and COVID-19, but of race and 214 
geography. The twindemic has implications for continued mitigation of disease spread, as well 215 
as vaccination strategies.  216 
There are many similarities in the Indiana trends with prior studies as well as national trends. 217 
Rates per capita for hospitalization and death increase with age.[4, 6, 20-22] Furthermore, 218 
hospitalization and death per capita was greater among men versus women,[21, 22] even 219 
though women experienced greater morbidity. Moreover, burden of COVID-19 within the 220 
African American community overall was much greater than its proportional composition of the 221 
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state’s population.[7] Per capita hospitalization among African Americans grew and remained 222 
highest among all sub-populations throughout the pandemic. Burden among American 223 
Indian/Native Alaskan and Native Hawaiian/Pacific Islander populations were also among the 224 
highest overall and during most time periods, a trend observed nationally. 225 
While the data in this study share much in common with prior studies, there are several unique 226 
characteristics that distinguish our work. First, the study uses a large repository of testing data 227 
linked to electronic medical records. Testing data includes results from hospital-based, 228 
commercial, and public health departments creating a comprehensive source measuring 229 
testing, as well as morbidity, per capita. Second, the study measures burden of disease and 230 
outcomes during the fall surge, something few studies to date have reported. Stratification by 231 
phase is also unique, allowing comparison of burden and outcomes over time. These methods 232 
would not be possible without a robust electronic data infrastructure in Indiana aided by a 16+ 233 
year health information exchange[23] that partnered with the state health department, county 234 
health departments, and health care systems in response to the COVID-19 pandemic.[16] This 235 
multi-sector approach aligns with the vision set forth by the Public Health 3.0 framework 236 
described by DeSalvo et al.[24, 25] 237 
Although prior studies document racial disparities, especially during the initial phase of the 238 
pandemic, this study presents data on racial disparities in COVID-19 morbidity, hospitalization, 239 
and mortality over time. Rates, adjusted for population size, clearly show significant burden on 240 
African American populations during each phase of the pandemic. Although deaths per capita 241 
were lower than other racial groups in the fall surge, the cumulative mortality is 50% higher 242 
than mortality among White populations. Moreover, burden among Native Hawaiian/Pacific 243 
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Islander populations, albeit they account for a small percentage of the overall population, is 244 
nearly 10 times that of Whites. Among those who did not disclose or reported their race as 245 
‘Other,’ is 3-4 times higher than Whites. It is not unreasonable to assume that many Hispanics 246 
may be in that group. Therefore, we conclude that while racial disparities narrowed later in the 247 
pandemic, especially as burden shifted from urban to rural communities, cumulative burden on 248 
racial minorities from COVID-19 are severe. The burden on minority populations exacerbates 249 
existing health disparities, necessitating action as the nation attempts to both mitigate further 250 
disease spread and protect vulnerable populations through vaccination. 251 
Another distinguishing feature of this analysis is a focus on rural communities. A brief report on 252 
COVID-19 incidence thru October 2020 from the U.S. Centers for Disease Control and 253 
Prevention[26] revealed that morbidity was shifting nationally from urban to rural areas 254 
beginning in late summer. These trends are mirrored in this study. Yet this study further 255 
provides evidence on hospitalizations and mortality, which both surpassed urban rates per 256 
capita around the same time. Rural morbidity is of great concern, as many of these areas are 257 
medically underserved. Hospitals in rural areas may possess few ICU beds, and they may lack 258 
the staff necessary to handle an influx of COVID-19 cases.[27] During the fall surge, we 259 
observed several rural hospitals in Indiana reaching capacity quickly, necessitating transfers to 260 
urban centers, in many cases, more than 2 hours away from the resident’s home. This placed 261 
additional burden on urban hospitals already managing increased workload and burden from 262 
local residents infected with COVID-19. The situation further caused a response from public 263 
health in which elective procedures were reduced by order of the Governor, placing financial 264 
strain on both rural and urban facilities. More attention is needed on the impact of COVID-19 in 265 
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rural areas, combined with reasonable policies to support rural mitigation strategies and 266 
equitable distribution of vaccines to rural populations. 267 
Limitations 268 
This observational study has several limitations worth noting. Observational clinical data (e.g., 269 
“real-world evidence”), from which much of our findings are derived, is known to have 270 
potential biases.[28] First, a significant number of race classifications were reported as Other or 271 
Unknown. Similarly, the dataset could not identify ethnicity, as these data are also missing for 272 
many patients. Medical records as well as other health information systems, must improve the 273 
capture rates for race and ethnicity to enable large scale measurement of health disparities so 274 
public health can work with health systems to ensure health for all persons.[29, 30] Second, 275 
these data represent hospitalizations and death among individuals from one state. The patterns 276 
observed in Indiana may not generalize to all geographic regions of the U.S. or other countries. 277 
Public Health Implications 278 
This study offers several implications for public health in the wake of the COVID-19 pandemic. 279 
First, trends demonstrate a flattening of the curve following the initial stay-at-home order from 280 
public health authorities. As the state re-opened, morbidity and mortality increased during 281 
subsequent phases. This suggests aggressive mitgation for a longer period of time may be 282 
necessary for stronger mitigation. Moreover, sub-population differences highlight the need for 283 
more nuanced mitigation policies, perhaps data-driven approaches, that can evolve as the 284 
pandemic unfolds. 285 
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As public health attempts to mitigate disease spread going forward, additional attention should 286 
be paid to racial minority and rural populations. Testing increased per capita among racial 287 
minority groups in Indiana, enabling better detection of morbidity. Equitable testing was not 288 
sufficient for stemming hospitalization due to COVID-19. Mortality decreased among minority 289 
groups in the latter phases, yet this might be attributable to improved clinical management 290 
rather than contact tracing and isolation which our data did not measure. With respect to rural 291 
populations, morbidity, hospitalization, and mortality steadily increased over time, suggesting 292 
perhaps rural county health departments struggled with mitigation strategies or rural 293 
populations ignored mask ordinances, restrictions on social gatherings, and/or other public 294 
health tactics. Anecdotally, we observed complaints from several rural county health officers 295 
that local authorities would not enforce ordinances and that residents overtly refused to 296 
comply with many policies. More research is necessary to confirm these observations and 297 
support the development of more robust mitigation policies. 298 
Strategies to vaccinate against COVID-19 need to explicitly address racial disparities. Poorer 299 
health outcomes among racial minorities is often attributable to lack of health care access,[31] 300 
including preventative medicine and vaccination. In a majority White state, we achieved equity 301 
in testing. This means we can achieve equity in testing. However, current policies focus on age 302 
and comorbid conditions to drive decisions about which populations should receive vaccines 303 
first. While age places individuals at higher risk of hospitalization and death, this study 304 
demonstrates that racial minorities and rural populations also should be prioritized given their 305 
morbidity and mortality. If health departments are serious about addressing social 306 
determinants and racial disparities, they must factor these phenomena into vaccination plans.  307 
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